We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HURN icon
976
Huron Consulting
HURN
$1.97B
$240K ﹤0.01%
3,499
+52
+2% +$3.38K
ROG icon
977
Rogers Corp
ROG
$2.13B
$240K ﹤0.01%
1,925
+279
+17% +$37.7K
ITA icon
978
iShares US Aerospace & Defense ETF
ITA
$14.5B
$239K ﹤0.01%
2,154
LOV
979
DELISTED
Spark Networks SE American Depositary Shares
LOV
$239K ﹤0.01%
52,889
AWI icon
980
Armstrong World Industries
AWI
$7.62B
$237K ﹤0.01%
2,525
INDY icon
981
iShares S&P India Nifty 50 Index Fund
INDY
$560M
$237K ﹤0.01%
6,149
-141
-2% -$5.29K
VMI icon
982
Valmont Industries
VMI
$9.33B
$237K ﹤0.01%
1,585
-129
-8% -$18.2K
PFF icon
983
iShares Preferred and Income Securities ETF
PFF
$13.2B
$236K ﹤0.01%
6,320
-627
-9% -$23.4K
HCA icon
984
HCA Healthcare
HCA
$92.8B
$235K ﹤0.01%
1,593
-56
-3% -$7.52K
IEV icon
985
iShares Europe ETF
IEV
$1.64B
$234K ﹤0.01%
5,000
-2,150
-30% -$96.6K
TYL icon
986
Tyler Technologies
TYL
$13.7B
$234K ﹤0.01%
781
+126
+19% +$35.1K
HTHT icon
987
Huazhu Hotels Group
HTHT
$13.2B
$233K ﹤0.01%
5,839
-392
-6% -$14.2K
TRIP icon
988
TripAdvisor
TRIP
$1.74B
$233K ﹤0.01%
7,700
-303
-4% -$10.2K
ITT icon
989
ITT
ITT
$17.8B
$232K ﹤0.01%
3,151
+399
+14% +$26.5K
VALE icon
990
Vale
VALE
$62.6B
$232K ﹤0.01%
17,689
WFC.PRL icon
991
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
$231K ﹤0.01%
160
TIF
992
DELISTED
Tiffany & Co.
TIF
$231K ﹤0.01%
1,734
-3,752
-68% -$443K
ETR icon
993
Entergy
ETR
$52.4B
$230K ﹤0.01%
3,862
-86
-2% -$5.07K
HOLX
994
DELISTED
Hologic
HOLX
$229K ﹤0.01%
4,394
+35
+0.8% +$1.74K
KBH icon
995
KB Home
KBH
$3.54B
$229K ﹤0.01%
6,692
+6,532
+4,083% +$226K
WIX icon
996
WIX.com
WIX
$2.45B
$229K ﹤0.01%
1,878
-500
-21% -$61.2K
BRC icon
997
Brady Corp
BRC
$4.6B
$225K ﹤0.01%
3,956
+127
+3% +$7.12K
OCFC icon
998
OceanFirst Financial
OCFC
$1.74B
$225K ﹤0.01%
8,829
CHL
999
DELISTED
China Mobile Limited
CHL
$224K ﹤0.01%
5,344
+1,922
+56% +$77.6K
WTW icon
1000
Willis Towers Watson
WTW
$29.9B
$223K ﹤0.01%
1,108
-4,482
-80% -$859K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.